Portal de Periódicos da CAPES

An approach of fatty acids and resveratrol in the prevention of COVID ‐19 severity

2020; Wiley; Volume: 35; Issue: 5 Linguagem: Inglês

10.1002/ptr.6956

1099-1573

Tung Hoang,

Metabolomics and Mass Spectrometry Studies

Phytotherapy ResearchVolume 35, Issue 5 p. 2269-2273 LETTER TO THE EDITOR An approach of fatty acids and resveratrol in the prevention of COVID-19 severity Tung Hoang, Corresponding Author Tung Hoang [email protected] [email protected] orcid.org/0000-0001-6653-3406 Institute of Research and Development, Duy Tan University, Da Nang, Vietnam Faculty of Pharmacy, Duy Tan University, Da Nang, Vietnam Correspondence Tung Hoang, Institute of Research and Development, Duy Tan University, Da Nang 550000, Vietnam. Email: [email protected]; [email protected]Search for more papers by this author Tung Hoang, Corresponding Author Tung Hoang [email protected] [email protected] orcid.org/0000-0001-6653-3406 Institute of Research and Development, Duy Tan University, Da Nang, Vietnam Faculty of Pharmacy, Duy Tan University, Da Nang, Vietnam Correspondence Tung Hoang, Institute of Research and Development, Duy Tan University, Da Nang 550000, Vietnam. Email: [email protected]; [email protected]Search for more papers by this author First published: 17 November 2020 https://doi.org/10.1002/ptr.6956Citations: 5Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookxLinkedInRedditWechat REFERENCES Behl, T., Kaur, I., Bungau, S., Kumar, A., Uddin, M. S., Kumar, C., … Arora, S. (2020). The dual impact of ACE2 in COVID-19 and ironical actions in geriatrics and pediatrics with possible therapeutic solutions. Life Sciences, 257, 118075. https://doi.org/10.1016/j.lfs.2020.118075 10.1016/j.lfs.2020.118075 CASPubMedWeb of Science®Google Scholar Beijers, R., Gosker, H. R., & Schols, A. (2018). Resveratrol for patients with chronic obstructive pulmonary disease: Hype or hope? Current Opinion in Clinical Nutrition and Metabolic Care, 21(2), 138–144. https://doi.org/10.1097/MCO.0000000000000444 10.1097/MCO.0000000000000444 CASPubMedWeb of Science®Google Scholar Chareonrungrueangchai, K., Wongkawinwoot, K., Anothaisintawee, T., & Reutrakul, S. (2020). Dietary factors and risks of cardiovascular diseases: An umbrella review. Nutrients, 12(4), 1088. https://doi.org/10.3390/nu12041088. 10.3390/nu12041088 CASPubMedWeb of Science®Google Scholar Cornell, K., Alam, M., Lyden, E., Wood, L., LeVan, T. D., Nordgren, T. M., … Hanson, C. (2019). Saturated fat intake is associated with lung function in individuals with airflow obstruction: Results from NHANES 2007-2012. Nutrients, 11(2), 317. https://doi.org/10.3390/nu11020317. 10.3390/nu11020317 CASWeb of Science®Google Scholar Den Hartogh, D. J., & Tsiani, E. (2019). Health benefits of resveratrol in kidney disease: Evidence from in vitro and in vivo studies. Nutrients, 11(7), 1624. https://doi.org/10.3390/nu11071624. 10.3390/nu11071624 Web of Science®Google Scholar Dyck, G. J. B., Raj, P., Zieroth, S., Dyck, J. R. B., & Ezekowitz, J. A. (2019). The effects of resveratrol in patients with cardiovascular disease and heart failure: A narrative review. International Journal of Molecular Sciences, 20(4), 904. https://doi.org/10.3390/ijms20040904. 10.3390/ijms20040904 CASWeb of Science®Google Scholar Gheblawi, M., Wang, K., Viveiros, A., Nguyen, Q., Zhong, J. C., Turner, A. J., … Oudit, G. Y. (2020). Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: Celebrating the 20th anniversary of the discovery of ACE2. Circulation Research, 126(10), 1456–1474. https://doi.org/10.1161/CIRCRESAHA.120.317015 10.1161/CIRCRESAHA.120.317015 CASPubMedWeb of Science®Google Scholar Hirayama, F., Lee, A. H., Binns, C. W., Hiramatsu, N., Mori, M., & Nishimura, K. (2010). Dietary intake of isoflavones and polyunsaturated fatty acids associated with lung function, breathlessness and the prevalence of chronic obstructive pulmonary disease: Possible protective effect of traditional Japanese diet. Molecular Nutrition & Food Research, 54(7), 909–917. https://doi.org/10.1002/mnfr.200900316 10.1002/mnfr.200900316 CASPubMedWeb of Science®Google Scholar Hoang, T., & Kim, J. (2020). Comparative effect of statins and omega-3 supplementation on cardiovascular events: Meta-analysis and network meta-analysis of 63 randomized controlled trials including 264,516 participants. Nutrients, 12(8), 2218. https://doi.org/10.3390/nu12082218. 10.3390/nu12082218 CASWeb of Science®Google Scholar Hoang, T., & Tran, T. A. T. (2020). Comparison of comorbidities in relation to critical conditions among COVID-19 patients: a network meta-analysis. https://doi.org/10.13140/RG.2.2.28551.83365 Google Scholar Horne, J. R., & Vohl, M. C. (2020). Biological plausibility for interactions between dietary fat, resveratrol, ACE2, and SARS-CoV illness severity. American Journal of Physiology. Endocrinology and Metabolism, 318(5), E830–E833. https://doi.org/10.1152/ajpendo.00150.2020 10.1152/ajpendo.00150.2020 CASPubMedWeb of Science®Google Scholar Indini, A., Rijavec, E., Ghidini, M., Bareggi, C., Cattaneo, M., Galassi, B., … Grossi, F. (2020). Coronavirus infection and immune system: An insight of COVID-19 in cancer patients. Critical Reviews in Oncology/Hematology, 153, 103059. https://doi.org/10.1016/j.critrevonc.2020.103059 10.1016/j.critrevonc.2020.103059 PubMedWeb of Science®Google Scholar Jung, S. Y., Choi, J. C., You, S. H., & Kim, W. Y. (2020). Association of renin-angiotensin-aldosterone system inhibitors with COVID-19-related outcomes in Korea: A nationwide population-based cohort study. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaa624 Web of Science®Google Scholar Kitada, M., & Koya, D. (2013). Renal protective effects of resveratrol. Oxidative Medicine and Cellular Longevity, 2013, 568093. https://doi.org/10.1155/2013/568093. 10.1155/2013/568093 CASPubMedWeb of Science®Google Scholar Ko, J. H., Sethi, G., Um, J. Y., Shanmugam, M. K., Arfuso, F., Kumar, A. P., … Ahn, K. S. (2017). The role of resveratrol in cancer therapy. International Journal of Molecular Sciences, 18(12), 2589. https://doi.org/10.3390/ijms18122589. 10.3390/ijms18122589 PubMedWeb of Science®Google Scholar Lee, K. H., Seong, H. J., Kim, G., Jeong, G. H., Kim, J. Y., Park, H., … Gamerith, G. (2020). Consumption of fish and omega-3 fatty acids and cancer risk: An umbrella review of meta-analyses of observational studies. Advances in Nutrition, 11, 1134–1149. https://doi.org/10.1093/advances/nmaa055 10.1093/advances/nmaa055 PubMedWeb of Science®Google Scholar Lin, S. C., Ho, C. T., Chuo, W. H., Li, S., Wang, T. T., & Lin, C. C. (2017). Effective inhibition of MERS-CoV infection by resveratrol. BMC Infectious Diseases, 17(1), 144. https://doi.org/10.1186/s12879-017-2253-8 10.1186/s12879-017-2253-8 PubMedWeb of Science®Google Scholar Ma, Z., Zhang, Y., Li, Q., Xu, M., Bai, J., & Wu, S. (2017). Resveratrol improves alcoholic fatty liver disease by downregulating HIF-1alpha expression and mitochondrial ROS production. PLoS One, 12(8), e0183426. https://doi.org/10.1371/journal.pone.0183426 10.1371/journal.pone.0183426 PubMedWeb of Science®Google Scholar Malaguarnera, L. (2019). Influence of resveratrol on the immune response. Nutrients, 11(5), 946. https://doi.org/10.3390/nu11050946. 10.3390/nu11050946 CASPubMedWeb of Science®Google Scholar Malhotra, R., Cavanaugh, K. L., Blot, W. J., Ikizler, T. A., Lipworth, L., & Kabagambe, E. K. (2016). Dietary polyunsaturated fatty acids and incidence of end-stage renal disease in the southern community cohort study. BMC Nephrology, 17(1), 152. https://doi.org/10.1186/s12882-016-0371-y 10.1186/s12882-016-0371-y PubMedWeb of Science®Google Scholar McKeever, T. M., Lewis, S. A., Cassano, P. A., Ocke, M., Burney, P., Britton, J., & Smit, H. A. (2008). The relation between dietary intake of individual fatty acids, FEV1 and respiratory disease in Dutch adults. Thorax, 63(3), 208–214. https://doi.org/10.1136/thx.2007.090399 10.1136/thx.2007.090399 CASPubMedWeb of Science®Google Scholar Ni, W., Yang, X., Yang, D., Bao, J., Li, R., Xiao, Y., … Gao, Z. (2020). Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19. Critical Care, 24(1), 422. https://doi.org/10.1186/s13054-020-03120-0 10.1186/s13054-020-03120-0 PubMedWeb of Science®Google Scholar Perdomo, C. M., Fruhbeck, G., & Escalada, J. (2019). Impact of nutritional changes on nonalcoholic fatty liver disease. Nutrients, 11(3), 677. https://doi.org/10.3390/nu11030677. 10.3390/nu11030677 CASPubMedWeb of Science®Google Scholar Radzikowska, U., Rinaldi, A. O., Celebi Sozener, Z., Karaguzel, D., Wojcik, M., Cypryk, K., … Sokolowska, M. (2019). The influence of dietary fatty acids on immune responses. Nutrients, 11(12), 2990. https://doi.org/10.3390/nu11122990. 10.3390/nu11122990 CASPubMedWeb of Science®Google Scholar Rawal, G., & Yadav, S. (2015). Nutrition in chronic obstructive pulmonary disease: A review. Journal of Translational Internal Medicine, 3(4), 151–154. https://doi.org/10.1515/jtim-2015-0021 10.1515/jtim-2015-0021 PubMedWeb of Science®Google Scholar Rice Bradley, B. H. (2018). Dietary fat and risk for type 2 diabetes: A review of recent research. Current Nutrition Reports, 7(4), 214–226. https://doi.org/10.1007/s13668-018-0244-z 10.1007/s13668-018-0244-z PubMedGoogle Scholar Schuler, R., Osterhoff, M. A., Frahnow, T., Seltmann, A. C., Busjahn, A., Kabisch, S., … Pfeiffer, A. F. (2017). High-saturated-fat diet increases circulating angiotensin-converting enzyme, which is enhanced by the rs4343 polymorphism defining persons at risk of nutrient-dependent increases of blood pressure. Journal of the American Heart Association, 6(1), e004465. https://doi.org/10.1161/JAHA.116.004465. 10.1161/JAHA.116.004465 PubMedWeb of Science®Google Scholar Ullah, R., Rauf, N., Nabi, G., Ullah, H., Shen, Y., Zhou, Y. D., & Fu, J. (2019). Role of nutrition in the pathogenesis and prevention of non-alcoholic fatty liver disease: Recent updates. International Journal of Biological Sciences, 15(2), 265–276. https://doi.org/10.7150/ijbs.30121 10.7150/ijbs.30121 CASPubMedWeb of Science®Google Scholar Varraso, R., Barr, R. G., Willett, W. C., Speizer, F. E., & Camargo, C. A., Jr. (2015). Fish intake and risk of chronic obstructive pulmonary disease in 2 large US cohorts. The American Journal of Clinical Nutrition, 101(2), 354–361. https://doi.org/10.3945/ajcn.114.094516 10.3945/ajcn.114.094516 CASPubMedWeb of Science®Google Scholar Verdecchia, P., Cavallini, C., Spanevello, A., & Angeli, F. (2020). The pivotal link between ACE2 deficiency and SARS-CoV-2 infection. European Journal of Internal Medicine, 76, 14–20. https://doi.org/10.1016/j.ejim.2020.04.037 10.1016/j.ejim.2020.04.037 CASPubMedWeb of Science®Google Scholar Vervandier-Fasseur, D., & Latruffe, N. (2019). The potential use of resveratrol for cancer prevention. Molecules, 24(24), 4506. https://doi.org/10.3390/molecules24244506. 10.3390/molecules24244506 CASWeb of Science®Google Scholar Wang, L., Manson, J. E., Forman, J. P., Gaziano, J. M., Buring, J. E., & Sesso, H. D. (2010). Dietary fatty acids and the risk of hypertension in middle-aged and older women. Hypertension, 56(4), 598–604. https://doi.org/10.1161/HYPERTENSIONAHA.110.154187 10.1161/HYPERTENSIONAHA.110.154187 CASPubMedWeb of Science®Google Scholar Xiao, Q., Zhu, W., Feng, W., Lee, S. S., Leung, A. W., Shen, J., … Xu, C. (2018). A review of resveratrol as a potent chemoprotective and synergistic agent in cancer chemotherapy. Frontiers in Pharmacology, 9, 1534. https://doi.org/10.3389/fphar.2018.01534 10.3389/fphar.2018.01534 CASPubMedWeb of Science®Google Scholar Zhang, H., Penninger, J. M., Li, Y., Zhong, N., & Slutsky, A. S. (2020). Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: Molecular mechanisms and potential therapeutic target. Intensive Care Medicine, 46(4), 586–590. https://doi.org/10.1007/s00134-020-05985-9 10.1007/s00134-020-05985-9 CASPubMedWeb of Science®Google Scholar Zhu, Y., Bo, Y., & Liu, Y. (2019). Dietary total fat, fatty acids intake, and risk of cardiovascular disease: A dose-response meta-analysis of cohort studies. Lipids in Health and Disease, 18(1), 91. https://doi.org/10.1186/s12944-019-1035-2 10.1186/s12944-019-1035-2 PubMedWeb of Science®Google Scholar Citing Literature Volume35, Issue5May 2021Pages 2269-2273 This article also appears in:Phytocompounds and COVID-19: two years of knowledge ReferencesRelatedInformation